Article Type
Article
Changed
Tue, 05/07/2019 - 10:25
Display Headline
Lipid-regulating and antiatherosclerotic therapy: Current options and future approaches
Article PDF
media_3842309_ccjm63_1-0041.pdf
Author and Disclosure Information

 

DONALD G. VIDT, MD

ANTONIO M. GOTTO, MD, Dphil

Address reprint requests to A.M.G., Department of Medicine, Baylor College of Medicine, 6550 Fannin, Suite 1423, Houston, TX 77030.
Issue
Cleveland Clinic Journal of Medicine - 63(1)
Publications
Cleveland Clinic Journal of Medicine
Page Number
31-41
Legacy Keywords
HYPERCHOLESTEROLEMIA, RISK FACTOR REDUCTION, LIPID-LOWERING AGENTS
Sections
Current Drug Therapy
Author and Disclosure Information

 

DONALD G. VIDT, MD

ANTONIO M. GOTTO, MD, Dphil

Address reprint requests to A.M.G., Department of Medicine, Baylor College of Medicine, 6550 Fannin, Suite 1423, Houston, TX 77030.
Author and Disclosure Information

 

DONALD G. VIDT, MD

ANTONIO M. GOTTO, MD, Dphil

Address reprint requests to A.M.G., Department of Medicine, Baylor College of Medicine, 6550 Fannin, Suite 1423, Houston, TX 77030.
Article PDF
media_3842309_ccjm63_1-0041.pdf
Article PDF
media_3842309_ccjm63_1-0041.pdf
Issue
Cleveland Clinic Journal of Medicine - 63(1)
Issue
Cleveland Clinic Journal of Medicine - 63(1)
Page Number
31-41
Page Number
31-41
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Article Type
Article
Display Headline
Lipid-regulating and antiatherosclerotic therapy: Current options and future approaches
Display Headline
Lipid-regulating and antiatherosclerotic therapy: Current options and future approaches
Legacy Keywords
HYPERCHOLESTEROLEMIA, RISK FACTOR REDUCTION, LIPID-LOWERING AGENTS
Legacy Keywords
HYPERCHOLESTEROLEMIA, RISK FACTOR REDUCTION, LIPID-LOWERING AGENTS
Sections
Current Drug Therapy
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media